七月 2026
- Home
- Windlas Biotech
七月 2026的Windlas Biotech市场份额分析
Learn the Monitoring Agency overseeing Windlas Biotech’s IPO fund usage, ensuring transparency, accountability, & proper fund deployment.
Windlas Biotech(包含公司地区分支机构)
查看更多网站流量和参与度信息- windlas.com
Windlas Biotech收入截至 七月 2026为 75M - 100M
Windlas Biotech主要域名产生的收入
3 年中Windlas Biotech主要域名的收入
Windlas Biotech主要域名的收入
Windlas Biotech热门域名的总访问量
了解Windlas Biotech市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Windlas Biotech热门域名的平均访问时长
分析Windlas Biotech参与度指标。
过去 3 个月的平均访问时长
子公司明细
Windlas Biotech热门域名的平均页面浏览量
了解Windlas Biotech如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Windlas Biotech 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Windlas Biotech Limited had revenue of $26M on Jun 30th '26.Windlas Biotech Limited (NSE:WINDLAS) informed stock exchanges on 10 August 2026 that its Board of Directors approved unaudited standalone financial results for the quarter ended 30 June 2026, with revenue from operations reaching Rs 2,480.99 million and profit after tax of Rs 176.53 million.
八月 10, 2026阅读更多
新闻Windlas Biotech Limited hires Shailendra Rastogi as Chief Business Officer.Windlas Biotech Limited, one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India has further strengthened the senior management capability with the appointment of Shailendra Rastogi as a Chief Business Officer.
十二月 22, 2021阅读更多
新闻Windlas Biotech Limited went public on Aug 4th '21.(Image: Windlas Biotech) Windlas Biotech IPO share allotment status: The initial public offering (IPO) of Windlas Biotech, a manufacturer of pharmaceutical formulations, was subscribed 22.47 times over the 61.36 lakh shares that were on offer during the subscription period from August 4-6, 2021.
八月 10, 2021阅读更多
查看 Windlas Biotech 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
